No Image Provided

Decently

VC Funding

Series A

Healthcare & Biotech Published 20 September 2023

Summary

In a significant market movement during September 2023, Decently was the subject of a vc funding. The transaction achieved a gross valuation of £500,000. Leading the round was SFC Capital, Bruntwood SciTech, Greater Manchester Combined Authority (GMCA), Cheshire & Warrington LEP, GMC Life Sciences Fund.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

SFC Capital

Lead Investor / Acquirer

Bruntwood SciTech

Lead Investor / Acquirer

Greater Manchester Combined Authority (GMCA)

Lead Investor / Acquirer

Cheshire

Lead Investor / Acquirer

Warrington LEP

Lead Investor / Acquirer

GMC Life Sciences Fund

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series A prioritised

VC Funding

Newcells Biotech

£2,350,000

Feb 2024

VC Funding

HutanBio

£2,250,000

Jan 2024

VC Funding

Lottie

£17,253,062

Oct 2023

VC Funding

Skin Analytics

£4,000,000

Sept 2020

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.